Opsiscare Lifesciences Pvt Ltd
Glimepiride (3mg) + Metformin (500mg)
Opglim M 3mg/500mg Tablet is a combination of two medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Tablet
Opglim M 3mg/500mg Tablet belongs to a category of medicines known as anti-diabetic drugs. It is a combination of two medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Opglim M 3mg/500mg Tablet is to be taken with food.
No common side effects listed.
It is unsafe to consume alcohol with Opglim M 3mg/500mg Tablet.
Opglim M 3mg/500mg Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Opglim M 3mg/500mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Opglim M 3mg/500mg Tablet is a combination of two antidiabetic medicines: Glimepiride and Metformin. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose. Metformin is a biguanide which works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body's sensitivity to insulin.
You should continue to exercise regularly eat a healthy diet and take your other diabetes medicines along with Opglim M 3mg/500mg Tablet.
Store this medicine in the container or the pack it came in, tightly closed. Follow the instructions on the pack or label regarding storage. Dispose of unused medication.
Yes, using Opglim M 3mg/500mg Tablet can increase the risk of lactic acidosis. This is a rare but serious condition that involves an excessive build-up of lactic acid in the body and requires immediate medical attention. It is also associated with metformin use and more likely to occur in individuals with pre-existing kidney disease, elderly patients, or those who consume large amounts of alcohol.
Opglim M 3mg/500mg Tablet is a combination medicine containing two components: Glimepiride and Metformin. It's used to treat type 2 diabetes mellitus (DM). This combination helps control blood glucose levels in adults when combined with proper diet and exercise.
Common side effects include hypoglycemia (low blood sugar), altered taste, nausea, stomach pain, diarrhea, and headache. In rare cases, severe side effects like lactic acidosis may occur. Over time, long-term use of this medication can lead to Vitamin B12 deficiency.
Yes, long-term use of Opglim M 3mg/500mg Tablet may lead to Vitamin B12 deficiency. This is because it can interfere with the absorption of Vitamin B12 in the stomach. Untreated Vitamin B12 deficiency can lead to anemia and other neurological problems, including tingling or numbness in hands and feet, weakness, urinary issues, change in mental status, and difficulty maintaining balance (ataxia). To prevent this, regular intake of Vitamin B12 from external sources is recommended at least once a year.
Yes, using Opglim M 3mg/500mg Tablet can lead to hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feelings of anxiety or shakiness. Hypoglycemia is more likely if missed meals are combined with drinking alcohol, exercise, and taking other antidiabetic drugs.
No, combining alcohol with Opglim M 3mg/500mg Tablet can be unsafe as it may lead to low blood sugar levels and increase the risk of lactic acidosis. It's essential to avoid alcohol consumption while using this medication.